A Study of Asciminib Safety and Efficacy in Young Adults With Chronic Myeloid Leukemia in the Gulf Region
7d agoen
From the article
Conditions : Chronic Myeloid Leukemia Sponsors : Novartis Pharmaceuticals Not yet recruiting
Continue reading on clinicaltrials.govYou might also wanna read
CCR study reveals how leukemia chemotherapy drug Ara-C damages neurons causing balance problems
CCR scientists led by Andre Nussenzweig have discovered why the chemotherapy drug Ara-C (used to treat blood cancers) causes movement and ba
The Evolving Role of Targeted Therapies in Chronic Lymphocytic Leukemia Care
ltcnews.com·13d ago
.png?width=720&quality=80&disable=upscale)
Dodging the cytokine storm: Delivering ASOs without adverse effects
bioprocessintl.com·27d ago
Anixa Biosciences Aktie: Höchste Lira-cel-Dosis erreicht
aktiencheck.de

MATCH cohort provides regulatory-ready external control framework for MSUD gene therapy trials
This article presents the MSUD Age-matched Standard Treatment Cohort (MATCH), a prospective natural history study of 11 infants with classic
cell.com·19d ago

MATCH cohort provides regulatory-ready external control framework for MSUD gene therapy trials
This article presents the MSUD Age-matched Standard Treatment Cohort (MATCH), a prospective natural history study of 11 infants with classic
cell.com·19d ago
Avacta Therapeutics presents platform-validating data for faridoxorubicin in salivary gland cancer at BIO International Conference
Avacta Therapeutics announced platform-validating clinical data for faridoxorubicin (AVA6000), a tumor-activated oncology drug using its pre

Comments
Sign in to join the conversation.
No comments yet. Be the first.